<Disease><Name>EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32</Name><Synonym /><OMIM><Number>616366</Number><URL>http://omim.org/entry/616366</URL></OMIM><Orphanet><Number>442835</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=442835</URL></Orphanet><Protein><Number>Potassium voltage-gated channel subfamily A member 2</Number><URL>https://www.uniprot.org/uniprot/P16389</URL></Protein><ExPASy><Number /><URL /></ExPASy><Gene>1p13.3</Gene><ICD>G40.4</ICD><Summary>rare;autosomal dominant;mutation in the KCNA2 gene</Summary><Symptoms><symtomp><id>1942</id><symptom>ataxia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2105</id><symptom>encephalopathy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3709</id><symptom>epilepsy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3826</id><symptom>intellectual disability/intellectual developmental disorder</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1886</id><symptom>microcephaly (&lt;2 SD for age)</symptom><category>HEAD</category></symtomp><symtomp><id>1900</id><symptom>myoclonus</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>1974</id><symptom>spastic diplegia/quadriplegia/tetraplegia</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp></Symptoms><Metabolites><metabolite><id>502</id><name>no specific laboratory findings (P, S, U ,CSF)</name><specimen /><value /><min>    </min><max>    </max><unit /><age>no data</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>7023</id><title>Progressive myoclonus epilepsy caused by a gain-of-function KCNA2 mutation</title><author>Canafoglia L,</author><journal>Seizure</journal><year>2019</year><book /><volume>65</volume><number>0</number><pages>106-108</pages><co_aut>et al.</co_aut></literature><literature><id>7024</id><title>Novel clinical manifestations in patients with KCNA2 mutations</title><author>Sachdev M,</author><journal>Seizure</journal><year>2017</year><book /><volume>51</volume><number>0</number><pages>74-76</pages><co_aut>et al.</co_aut></literature><literature><id>7025</id><title>Clinical spectrum and genotype-phenotype associations of KCNA2-related encephalopathies</title><author>Masnada S,</author><journal>Brain</journal><year>2017</year><book /><volume>140</volume><number>9</number><pages>2337-2354</pages><co_aut>et al.</co_aut></literature><literature><id>7026</id><title>De novo KCNA2 mutations cause hereditary spastic paraplegia</title><author>Manole A,</author><journal>Ann Neurol</journal><year>2017</year><book /><volume>81</volume><number>2</number><pages>326-328</pages><co_aut>et al.</co_aut></literature><literature><id>7027</id><title>KCNA2 mutations are rare in hereditary spastic paraplegia</title><author>Gan-Or Z,</author><journal>Ann Neurol</journal><year>2017</year><book /><volume>81</volume><number>2</number><pages>326-326</pages><co_aut>et al.</co_aut></literature><literature><id>7028</id><title>Dominant KCNA2 mutation causes episodic ataxia and pharmacoresponsive epilepsy</title><author>Corbett MA,</author><journal>Neurology</journal><year>2016</year><book /><volume>87</volume><number>19</number><pages>1975-1984</pages><co_aut>et al.</co_aut></literature><literature><id>7029</id><title>A recurrent mutation in KCNA2 as a novel cause of hereditary spastic paraplegia and ataxia</title><author>Helbig KL,</author><journal>Ann Neurol</journal><year>2016</year><book /><volume>80</volume><number>4</number><pages /><co_aut>et al.</co_aut></literature><literature><id>7030</id><title>Severe early-onset epileptic encephalopathy due to mutations in the KCNA2 gene: Expansion of the genotypic and phenotypic spect</title><author>Hundallah K,</author><journal>Eur J Paediatr Neurol</journal><year>2016</year><book /><volume>20</volume><number>4</number><pages>657-660</pages><co_aut>et al.</co_aut></literature><literature><id>7022</id><title>De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy</title><author>Syrbe S,</author><journal>Nat Genet</journal><year>2015</year><book /><volume>47</volume><number>4</number><pages>393-399</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>